Document is current
Any future updates will be listed below
-
Authors
Liu, Jian
Bian, Tingting
She, Bin
Liu, Lei
Sun, Hui
Zhang, Qing
Zhu, Jun
Zhang, Jianguo
Liu, Yifei
-
Funding
Funding for this research was provided by:
Nantong Municipal Science and technology project (JCZ0001)
Nantong Basic Research Plan Project (JC12022016, JC22022020, JC2021029)
Research project on cutting-edge tumor support therapy (cphcf-2022-206)
Jiangsu Provincial Research Hospital Hospital (YJXYY202204 YSC01, YJXYY202204 YSB01)
Shanghai Pudong New District Foundation for Development of Science and Technology (PKX2021-S09)
National Natural Science Foundation of China (No. 82273422)
- License Information
-
More Information
Article History
Received: 5 July 2023
Accepted: 19 February 2024
First Online: 2 March 2024
Declarations
:
: The study was approved by the institutional review board of Affiliated Hospital of Nantong University with the registration number 2021-L021 in accordance with the Declaration of Helsinki. All methods were carried out in accordance with relevant guidelines and regulations. Written informed consent was obtained from all individual patients included in the study.
: Not applicable.
: BS was employed by Tellgen Corporation, Shanghai, China. The remaining authors declare that the research was conducted without any commercial or financial relationships that could be perceived as a potential conflict of interest.
